116 related articles for article (PubMed ID: 34326124)
1. Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer.
Woff E; Salvatore L; Marmorino F; Genovesi D; Critchi G; Guiot T; Ameye L; Sclafani F; Hendlisz A; Flamen P
J Nucl Med; 2022 Apr; 63(4):549-555. PubMed ID: 34326124
[TBL] [Abstract][Full Text] [Related]
2. Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer.
Woff E; Hendlisz A; Ameye L; Garcia C; Kamoun T; Guiot T; Paesmans M; Flamen P
J Nucl Med; 2019 Feb; 60(2):178-184. PubMed ID: 29959212
[TBL] [Abstract][Full Text] [Related]
3. Combining
Woff E; Kehagias P; Vandeputte C; Ameye L; Guiot T; Paesmans M; Hendlisz A; Flamen P
J Nucl Med; 2019 Oct; 60(10):1366-1372. PubMed ID: 30850494
[TBL] [Abstract][Full Text] [Related]
4. Radiomics analysis of pre-treatment [
van Helden EJ; Vacher YJL; van Wieringen WN; van Velden FHP; Verheul HMW; Hoekstra OS; Boellaard R; Menke-van der Houven van Oordt CW
Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2307-2317. PubMed ID: 30094460
[TBL] [Abstract][Full Text] [Related]
5. Predicting tumor response and outcome of second-look surgery with
Aide N; Fauchille P; Coquan E; Ferron G; Combe P; Meunier J; Alexandre J; Berton D; Leary A; De Rauglaudre G; Bonichon N; Pujade Lauraine E; Joly F
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1998-2008. PubMed ID: 33221969
[TBL] [Abstract][Full Text] [Related]
6. Metabolic tumor burden quantified on [
Lapa P; Oliveiros B; Marques M; Isidoro J; Alves FC; Costa JMN; Costa G; de Lima JP
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2169-2178. PubMed ID: 28785842
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of the Pace of Tumor Progression as Assessed by Serial
Camera S; Akin Telli T; Woff E; Vandeputte C; Kehagias P; Guiot T; Critchi G; Wissam Y; Bregni G; Trevisi E; Pretta A; Senti C; Leduc S; Gkolfakis P; Hoerner F; Rothé F; Sclafani F; Flamen P; Deleporte A; Hendlisz A
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32987838
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of volume-based parameters using
Park JS; Lee N; Beom SH; Kim HS; Lee CK; Rha SY; Chung HC; Yun M; Cho A; Jung M
Gastric Cancer; 2018 Mar; 21(2):213-224. PubMed ID: 28643145
[TBL] [Abstract][Full Text] [Related]
9. 3'-Deoxy-3'-
Kim JE; Chae SY; Kim JH; Kim HJ; Kim TW; Kim KP; Kim SY; Lee JL; Oh SJ; Kim JS; Ryu JS; Moon DH; Hong YS
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1713-1722. PubMed ID: 31041456
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
11. Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma.
van Sluis J; de Heer EC; Boellaard M; Jalving M; Brouwers AH; Boellaard R
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1498-1510. PubMed ID: 33099667
[TBL] [Abstract][Full Text] [Related]
12.
Groheux D; Martineau A; Teixeira L; Espié M; de Cremoux P; Bertheau P; Merlet P; Lemarignier C
Breast Cancer Res; 2017 Jan; 19(1):3. PubMed ID: 28057031
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer.
Hendlisz A; Deleporte A; Delaunoit T; Maréchal R; Peeters M; Holbrechts S; Van den Eynde M; Houbiers G; Filleul B; Van Laethem JL; Ceyssens S; Barbuto AM; Lhommel R; Demolin G; Garcia C; El Mansy H; Ameye L; Moreau M; Guiot T; Paesmans M; Piccart M; Flamen P
PLoS One; 2015; 10(9):e0138341. PubMed ID: 26421426
[TBL] [Abstract][Full Text] [Related]
14. Repeatability of metabolically active tumor volume measurements with FDG PET/CT in advanced gastrointestinal malignancies: a multicenter study.
Frings V; van Velden FH; Velasquez LM; Hayes W; van de Ven PM; Hoekstra OS; Boellaard R
Radiology; 2014 Nov; 273(2):539-48. PubMed ID: 24865311
[TBL] [Abstract][Full Text] [Related]
15. The utility of
Kitajima K; Kawanaka Y; Komoto H; Minami T; Yokoi T; Kuribayashi K; Kijima T; Nakamura A; Hashimoto M; Kondo N; Hasegawa S; Yamakado K
Hell J Nucl Med; 2021; 24(3):186-198. PubMed ID: 34901959
[TBL] [Abstract][Full Text] [Related]
16. Early 18F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.
van Helden EJ; Hoekstra OS; Boellaard R; Roth C; Mulder ER; Verheul HM; Menke-van der Houven van Oordt CW
PLoS One; 2016; 11(5):e0155178. PubMed ID: 27196139
[TBL] [Abstract][Full Text] [Related]
17. Prediction of PSA Progression in Castration-Resistant Prostate Cancer Based on Treatment-Associated Change in Tumor Burden Quantified by 18F-Fluorocholine PET/CT.
Lee J; Sato MM; Coel MN; Lee KH; Kwee SA
J Nucl Med; 2016 Jul; 57(7):1058-64. PubMed ID: 26912444
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
Liao S; Penney BC; Wroblewski K; Zhang H; Simon CA; Kampalath R; Shih MC; Shimada N; Chen S; Salgia R; Appelbaum DE; Suzuki K; Chen CT; Pu Y
Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):27-38. PubMed ID: 21946983
[TBL] [Abstract][Full Text] [Related]
19. Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study.
Cardone C; De Stefano A; Rosati G; Cassata A; Silvestro L; Borrelli M; Di Gennaro E; Romano C; Nappi A; Zanaletti N; Foschini F; Casaretti R; Tatangelo F; Lastoria S; Raddi M; Bilancia D; Granata V; Setola S; Petrillo A; Vitagliano C; Gargiulo P; Arenare L; Febbraro A; Martinelli E; Ciardiello F; Delrio P; Budillon A; Piccirillo MC; Avallone A
ESMO Open; 2023 Feb; 8(1):100748. PubMed ID: 36603521
[TBL] [Abstract][Full Text] [Related]
20. Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with
Wibmer AG; Morris MJ; Gonen M; Zheng J; Hricak H; Larson S; Scher HI; Vargas HA
J Nucl Med; 2021 Aug; 62(8):1050-1056. PubMed ID: 33419944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]